Literature DB >> 8811757

Serum cholesterol concentration and death from suicide in men: Paris prospective study I.

M Zureik1, D Courbon, P Ducimetière.   

Abstract

OBJECTIVE: To investigate whether low serum cholesterol concentration or changing serum cholesterol concentration is associated with risk of suicide in men.
DESIGN: Cohort study with annual repeat measurements of serum cholesterol concentration (for up to four years).
SETTING: Paris, France.
SUBJECTS: 6393 working men, aged 43-52 in 1967-72, who had at least three measurements of serum cholesterol concentration. MAIN OUTCOME MEASURES: Individual change over time in serum cholesterol concentration (estimated using within person linear regression method); death from suicide during average of 17 years' follow up after last examination.
RESULTS: 32 men committed suicide during follow up. After adjustment for age and other factors, relative risk of suicide for men with low average serum cholesterol concentration (< 4.78 mmol/l) compared with those with average serum cholesterol concentration of 4.78-6.21 mmol/l was 3.16 (95% confidence interval 1.38 to 7.22, P = 0.007). Men whose serum cholesterol concentration decreased by more than 0.13 mmol/l a year had multivariate adjusted relative risk of 2.17 (0.97 to 4.84, P = 0.056) compared with those whose cholesterol remained stable (change of < or = 0.13 mmol/l a year).
CONCLUSION: Both low serum cholesterol concentration and declining cholesterol concentration were associated with increased risk of death from suicide in men. Although there is some evidence in favour of a concomitant rather than a causal effect for interpreting these associations, long term surveillance of subjects included in trials of lipid lowering treatments seems warranted.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811757      PMCID: PMC2351965          DOI: 10.1136/bmj.313.7058.649

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  9 in total

1.  Low serum cholesterol and suicide.

Authors:  H Engelberg
Journal:  Lancet       Date:  1992-03-21       Impact factor: 79.321

2.  Serum cholesterol concentrations in parasuicide. Depression may cause low cholesterol.

Authors:  M R Law; N J Wald
Journal:  BMJ       Date:  1995-09-23

3.  Low serum cholesterol concentration and serotonin metabolism in men.

Authors:  P H Steegmans; D Fekkes; A W Hoes; A A Bak; E van der Does; D E Grobbee
Journal:  BMJ       Date:  1996-01-27

4.  Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.

Authors:  M F Muldoon; S B Manuck; K A Matthews
Journal:  BMJ       Date:  1990-08-11

5.  Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.

Authors:  G Magni; M Garreau; B Orofiamma; R Palminteri
Journal:  Neuropsychobiology       Date:  1989       Impact factor: 2.328

6.  Assessing possible hazards of reducing serum cholesterol.

Authors:  M R Law; S G Thompson; N J Wald
Journal:  BMJ       Date:  1994-02-05

7.  [Suicide in Paris and Ile-de-France].

Authors:  D Lecomte; F Hatton; E Jougla; A Le Toullec
Journal:  Encephale       Date:  1995 Jan-Feb       Impact factor: 1.291

8.  Serum cholesterol concentrations in parasuicide.

Authors:  M Gallerani; R Manfredini; S Caracciolo; C Scapoli; S Molinari; C Fersini
Journal:  BMJ       Date:  1995-06-24

9.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

  9 in total
  38 in total

1.  Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts.

Authors:  L G Almeida-Montes; V Valles-Sanchez; J Moreno-Aguilar; R A Chavez-Balderas; J A García-Marín; J F Cortés Sotres; G Hheinze-Martin
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

Review 2.  Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.

Authors:  Beatrice Alexandra Golomb; Michael H Criqui; Halbert White; Joel E Dimsdale
Journal:  Arch Intern Med       Date:  2004-01-26

Review 3.  The serotonin1A receptor: a representative member of the serotonin receptor family.

Authors:  Thomas J Pucadyil; Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

4.  Functional foods: the case for closer evaluation.

Authors:  Nynke de Jong; Olaf H Klungel; Hans Verhagen; Marion C J Wolfs; Marga C Ocké; Hubert G M Leufkens
Journal:  BMJ       Date:  2007-05-19

5.  Combined biological tests for suicide prediction.

Authors:  William Coryell; Michael Schlesser
Journal:  Psychiatry Res       Date:  2007-02-07       Impact factor: 3.222

6.  Having too much evidence (depression, suicide, and low serum cholesterol)

Authors:  M Law
Journal:  BMJ       Date:  1996-09-14

7.  Lowered serum cholesterol and low mood.

Authors:  S L Brown
Journal:  BMJ       Date:  1996-09-14

8.  Fatty acid composition in postmortem brains of people who completed suicide.

Authors:  Aleksandra Lalovic; Emile Levy; Lilian Canetti; Adolfo Sequeira; Alain Montoudis; Gustavo Turecki
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

Review 9.  Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?

Authors:  Hiram Joseph Wildgust; Mike Beary
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

10.  Long-term statin use and psychological well-being.

Authors:  Yinong Young-Xu; K Arnold Chan; James K Liao; Shmuel Ravid; Charles M Blatt
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.